Coming soon from Redeye: Updated website and features - Click here for more information
Verdane has announced a recommended offer to the shareholders in Capilon to acquire all the shares and convertibles for SEK 29 in cash per share and convertible. The shares and convertibles are traded on NASDAQ First North. The offered share price implies a market cap of SEK 185m. Shareholders holding in aggregate approximately 34 per cent of the fully diluted share capital have accepted the offer. Capilon’s Board of Directors unanimously recommends the Company’s shareholders to accept the offer.
Verdane, a leading private equity company founded in Norway, is the Nordic market's largest manager of secondary direct funds. The funds advised by Verdane have acquired seventeen portfolios with stakes in over 200 companies.
Capilon is a listed private equity company focused on industrial investments. Capilon's business concept is to acquire and develop small and medium-sized industrial companies by being an active and professional owner. Principal businesses are Scanacon, MJP Waterjets and Österby Gjuteri.
Redeye is the exclusive financial advisor to Verdane.
For more information, contact:
Richard Goldman, Head of Corporate Finance
+46 761 84 11 11
Redeye AB is a specialist investment banking boutique that focuses on small and mid-cap growth companies in the Nordic region. We focus on the IT, life sciences, media, betting, clean tech and commodities sectors. We provide services within Corporate Broking, Corporate Finance, equity research, investor relations and media services. Our strengths are our award-winning research and analysis department, experienced advisers, a unique investor network, and powerful distribution channel redeye.se. Redeye was founded in 1999 and since 2007 has been subject to the supervision of the Swedish Financial Supervisory Authority.
|2012-02-21||Capilon - Public offer|
|2012-02-21||BioInvent - Rights issue|
|2012-02-06||Vd-byte på Redeye|
|2012-02-02||Redeye inleder analysbevakning av Caperio Holding|
|2012-01-23||Redeyes Life Science-favoriter för 2012|
|2011-11-30||Redeye advising Arctic Gold in SEK 10.5m private placement|
|2011-11-23||Redeye arranged IT-seminar with 15 presenting companies|
|2011-11-08||Redeye in cooperation with Nordnet arranged Börsdagarna|
|2011-10-13||Redeye arranged themed betting event focused on legal risks in the business|
|2011-10-06||Redeye arranged Exploration & Mining Seminar with 6 presenting companies|
|2011-07-15||Richard Goldman joins Redeye as Head of Corporate Finance|
|2011-07-01||Redeye advising Mintage Scientific AB in SEK 12m rights offering|
|2011-06-01||Redeye assisting in block transaction in Hansa Medical and Genovis|
|2011-05-26||Redeye in cooperation with Avanza arranged Börsdagarna|
|2011-05-01||Redeye assisting Moberg Derma in IPO|
|2011-04-01||Redeye assisting in private placement in Lociloci|
|2011-04-01||Redeye assisting in private placement in Connected Tables|
|2011-01-21||Redeyes fem IT-favoriter för 2011|
|2011-01-01||Redeye advising the divestment of allabolag.se|
|2011-01-01||Magnus Vestin joins Redeye as Director at Redeye Corporate Finance|
|2010-12-01||Redeye assisting InDex Pharmaceutical in private placement|
|2010-11-30||Redeye AB rådgivare åt Farstorp Invest i samband med offentligt bud på Biolin Scientific|
|2010-11-10||Sveriges första aktieanalys-app för din iPhone|
|2010-10-31||Samarbetet mellan Redeye och Tanglin upphör|